Tarbox Family Office, Inc. Pacira Bio Sciences, Inc. Transaction History

Tarbox Family Office, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 16, 2021	SELL	$59.18 - $69.99 $1,775 - $2,099	-30 Closed	0 $0
Q4 2020 Jan 27, 2021	SELL	$50.47 - $66.26 $454 - $596	-9 Reduced 23.08%	30 $2,000
Q2 2020 Jul 23, 2020	BUY	$30.8 - $52.47 $1,201 - $2,046	39 New	39 $2,000
Q1 2020 Apr 30, 2020	SELL	$28.4 - $50.7 $1,050 - $1,875	-37 Closed	0 $0
Q4 2019 Jan 31, 2020	BUY	$36.31 - $46.83 $1,343 - $1,732	37 New	37 $2,000

263

50.4M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $946M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Tarbox Family Office, Inc., based on Form 13F filings with the SEC.

Stay updated on Tarbox Family Office, Inc. with notifications on news.